Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · IEX Real-Time Price · USD

6.03

-0.24 (-3.83%)

At close: Jul 2, 2024, 4:00 PM

6.00

-0.03 (-0.50%)

After-hours: Jul 2, 2024, 5:05 PM EDT

Fennec Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2005
Market Capitalization	165	299	252	114	192	129	Upgrade
Market Cap Growth	37.14%	18.64%	120.12%	-40.49%	48.91%	2.58%	Upgrade
Enterprise Value	143	315	253	98	162	115	Upgrade
PE Ratio	201.00	-18.62	-10.62	-6.60	-10.62	-10.11	Upgrade
PS Ratio	3.67	14.06	164.09	-	1131.07	-	Upgrade
PB Ratio	54.66	-25.71	-98.05	7.26	6.61	10.87	Upgrade
P/FCF Ratio	6.00	-17.43	-13.95	-8.05	-12.33	-14.25	Upgrade
P/OCF Ratio	6.00	-17.43	-13.95	-8.05	-12.33	-14.25	Upgrade
EV/Sales Ratio	3.19	14.84	164.66	-	952.58	-	Upgrade
EV/EBITDA Ratio	17.69	-24.92	-11.12	-5.71	-8.95	-9.04	Upgrade
EV/EBIT Ratio	19.42	-24.92	-11.12	-5.71	-8.95	-9.04	Upgrade
EV/FCF Ratio	5.22	-18.39	-14.00	-6.91	-10.38	-12.75	Upgrade
Debt / Equity Ratio	9.87	-2.56	-9.59	0.32	-	-	Upgrade
Debt / EBITDA Ratio	3.67	-2.35	-1.08	-0.29	-	-	Upgrade
Debt / FCF Ratio	1.08	-1.73	-1.36	-0.35	-	-	Upgrade
Quick Ratio	6.25	2.92	5.49	12.76	12.93	6.01	Upgrade
Current Ratio	6.93	3.56	5.80	13.54	13.39	6.11	Upgrade
Asset Turnover	1.34	0.92	0.07	0	0.01	0	Upgrade
Interest Coverage	2.03	-3.73	-23.25	-136.67	-2011.11	-	Upgrade
Return on Equity (ROE)	-52.00%	147.50%	-445.40%	-84.60%	-69.10%	-81.70%	Upgrade
Return on Assets (ROA)	11.20%	-69.60%	-103.00%	-66.50%	-62.90%	-74.60%	Upgrade
Return on Capital (ROIC)	19.05%	-70.51%	-102.35%	-82.96%	-61.52%	-109.55%	Upgrade
Earnings Yield	2.28%	-5.37%	-9.41%	-15.16%	-9.42%	-9.89%	Upgrade
FCF Yield	16.68%	-5.74%	-7.17%	-12.43%	-8.11%	-7.02%	Upgrade
Buyback Yield / Dilution	-17.06%	-1.14%	-1.03%	-9.71%	-19.14%	-5.04%	Upgrade
Total Shareholder Return	-17.06%	-1.14%	-1.03%	-9.71%	-19.14%	-5.04%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).